News for Charles River Laboratories Stock (CRL)

What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?

Zacks Investment Research • 06/22/21

Charles River Laboratories: Stick With What Has Been Working

Seeking Alpha • 06/21/21

Charles River Laboratories Announces Long-Term Solar Contract for North American Operations

Business Wire • 06/07/21

Charles River Laboratories to Participate in June Investor Conferences

Business Wire • 05/28/21

Charles River's (CRAI) Forensic Services Practice Gets New VP

Zacks Investment Research • 05/20/21

Charles River (CRAI) Banking on Business Model, Debt Woe Stays

Zacks Investment Research • 05/18/21

Charles River Acquires Viral Vector Player For $350M

Benzinga • 05/17/21

Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities

Business Wire • 05/17/21

Charles River (CRAI) Beats on Q1 Earnings, Ups '21 Guidance

Zacks Investment Research • 05/12/21

Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PRNewsWire • 05/10/21

Charles River Labs International Joins Elite List Of Stocks With 95-Plus Composite Rating

Investors Business Daily • 05/05/21

Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha • 05/04/21

Charles River: Q1 Earnings Insights

Benzinga • 05/04/21

Charles River Laboratories Announces First-Quarter 2021 Results

Business Wire • 05/04/21

Three Scorching Medical Stocks To Watch, Including One Near A Buy Point

Investors Business Daily • 04/23/21

Charles River Laboratories International Inc (CRL) Corporate Executive VP & CFO David Ross.

GuruFocus • 04/16/21

Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call

Business Wire • 04/13/21

Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

Business Wire • 04/06/21

Charles River Laboratories Acquires Retrogenix

Business Wire • 03/31/21

Charles River Laboratories Completes the Acquisition of Cognate BioServices

Business Wire • 03/29/21

Clinical Trial Leaders PPD And CRL Stock Test New Buy Points

Investors Business Daily • 03/25/21

Charles River Laboratories Announces Closing of Senior Notes Offering

Business Wire • 03/23/21

Charles River Laboratories Prices $1 Billion of Senior Notes

Business Wire • 03/09/21

Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes

Business Wire • 03/08/21

Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies

Business Wire • 02/25/21